Citation Impact

Citing Papers

New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors
2022 StandoutNobel
Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma
2019
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
2020
Pathological Findings and Management of COVID-19 Patients: A Brief Overview of Modern-day Pandemic
2020
Cancer treatment and survivorship statistics, 2022
2022 Standout
Characteristics of SARS-CoV-2 and COVID-19
2020 Standout
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
A guide to manufacturing CAR T cell therapies
2018
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?
2020
SARS-CoV-2 was already spreading in France in late December 2019
2020
COVID-19: A promising cure for the global panic
2020 Standout
Genetically engineered T cells for cancer immunotherapy
2019
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Engineered T cells: the promise and challenges of cancer immunotherapy
2016
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
2016
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
2022
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
2020 Standout
Chimeric Antigen Receptor Therapy
2018 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
CAR T Cell Therapy: A Game Changer in Cancer Treatment
2016
Characterization of DNA Methylation in Circulating Tumor Cells
2015
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel

Works of Fengxia Shi being referenced

Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report
2016
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells
2016
Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial
2020
Low-Dose Decitabine-Based Chemoimmunotherapy for Patients with Refractory Advanced Solid Tumors: A Phase I/II Report
2014
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
2015
2019 Novel Coronavirus (COVID-19) Pneumonia with Hemoptysis as the Initial Symptom: CT and Clinical Features
2020
Rankless by CCL
2026